Related Experiment Videos
[Expression of p53 in the skin in systemic sclerosis. Immunohistochemical study of 8 cases]
A Pignone1, A Calzolari, M M Cerinic
1Istituto di Clinica Medica IV, Università di Firenze.
Abstract:
P53 gene belongs to the family of "Tumor suppressor gene". It encodes a nuclear phosphoprotein involved in cell proliferation control; mutations of p53 gene are the most common genetic alterations found in human tumors. These mutations may cause the production of an altered protein that usually loses its physiological function. The mutant p53 protein is more stable than the wild type form and it is immunohistochemically detectable. Systemic Sclerosis is characterized by activation of fibroblasts, endotheliocytes and lymphocytes; furthermore, in this disease, a proto-oncogenic activation has already been shown in fibroblasts and lymphocytes. The aim of this study was to verify p53 expression in the skin of SSc patients. Eight patients, all classified in the limited cutaneous subset of SSc, after informed consent, underwent skin biopsies of the affected and apparently unaffected skin. P53 was investigated by immunohistochemistry, using a monoclonal anti-p53 antibody (DO-7), on formalin fixed, paraffin embedded tissue. P53 immunoreactive cells were found in 4 out of 8 biopsies; in all cases the positivity was confined to cells of the basal layer of the epidermis, histologically identified as keratinocytes. A large case series and a molecular biology approach are needed to support these preliminary observations.
Insights
The tumor suppressor gene p53, crucial for cell proliferation control, was investigated in Systemic Sclerosis (SSc) skin. Preliminary findings indicate p53 expression in SSc skin keratinocytes, suggesting a potential role in this fibrotic disease.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Context:
- The p53 gene is a critical tumor suppressor involved in cell cycle regulation.
- Mutations in the p53 gene are common in human cancers, often leading to a stabilized, detectable mutant protein.
- Systemic Sclerosis (SSc) is a fibrotic disease characterized by fibroblast, endotheliocyte, and lymphocyte activation, with evidence of proto-oncogene activation.
Purpose:
- To investigate the expression of p53 protein in the skin of patients with Systemic Sclerosis (SSc).
Summary:
- This study utilized immunohistochemistry to examine p53 expression in skin biopsies from eight limited cutaneous SSc patients.
- P53 immunoreactivity was detected in the basal layer keratinocytes of the epidermis in 4 out of 8 SSc skin samples.
- These preliminary results suggest a potential role for p53 in the pathogenesis of SSc skin manifestations.
Impact:
- These findings highlight the need for larger studies with molecular approaches to confirm the role of p53 in SSc.
- Understanding p53 alterations in SSc could offer new insights into disease mechanisms and potential therapeutic targets.